Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL

1 answer:

8 0

TRANSCEND CLL 004 is a clinical trial that assesses a type of CAR T-cell therapy in patients suffering relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

<h3>What is CAR T-cell therapy?</h3>

The chimeric antigen receptor (CAR) T-cell therapy is a gene therapy based on genetic engineering to produce T cells that are able to target specific antigens.

The chimeric antigen receptor (CAR) T-cell therapy may result very useful to kill specific cancer cells.

In conclusion, TRANSCEND CLL 004 is a clinical trial that assesses a type of CAR T-cell therapy in patients suffering relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

Learn more about gene therapy here:

brainly.com/question/315648

#SPJ1

You might be interested in

Cual es la mejor expresión para promover una visita al teatro

OverLord2011 [107]

Which is the best expression to promote a visit to the theater

6 0

3 years ago

Read 2 more answers

Need Assistance<br>*Please Show Work*

user100 [1]

Answer: 3/8 of the class went to the evening session.

Explanation:

So it says on Sunday 3/4 of an 8th grade class went to see the movie.But we do not know the real population of the 8th grade class. But is says that out of the 3/4 of the students that went to the movie have of them went in the afternoon so we will multiply 1/2 by 3/4 to find out how many people went to the afternoon session.

3/4 * 1/2 = 3/8 So we know that 3/8 of the 3/4 of the class went in the afternoon so we will now subtract 3/8 from 3/4 to find out what fraction went in the evening.

$\frac{3}{4} - \frac{3}{8}$ = $\frac{6}{8} - \frac{3}{8} = \frac{3}{8}$